deoxycytidine has been researched along with Pleural Effusion, Malignant in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (61.54) | 29.6817 |
2010's | 5 (38.46) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bao, YT; Li, CM; Liu, ZC; Sun, XD; Wang, LL | 1 |
Afghani, R; Azarhoush, R; Hajimohammadi, A; Kazemi-Nejad, V; Rezapour Esfahani, M; Yari, B | 1 |
Anghinolfi, M; Casalini, AG; Gnetti, L; Majori, M | 1 |
Hillerdal, G; Hjerpe, A; Riska, H; Sorensen, JB; Sundström, S; Vikström, A | 1 |
Choi, JH; Choi, YW; Han, JH; Hwang, SC; Jeong, SH; Jung, JH; Kang, SY; Kim, JH; Lee, HW; Oh, YT; Park, KJ; Sheen, SS | 1 |
Dodič-Fikfak, M; Dolžan, V; Erčulj, N; Franko, A; Hmeljak, J; Kovač, V | 1 |
Chen, X; Guo, R; Jin, S; Liu, Y; Ping, G; Røe, OD; Shu, Y; Yan, K; Yin, Y | 1 |
Chen, CW; Chen, HH; Chen, TY; Hsiue, TR; Huang, WT; Lai, WW; Su, WC; Tsao, CJ; Wang, NS | 1 |
Hitsuda, Y; Kawasaki, Y; Koshohbu, T; Matsumoto, S; Nakatani, S; Shimizu, E; Yasuda, K | 1 |
Futagawa, T; Izumi, H; Miyamoto, H; Oh, T; Sonobe, S; Yamazaki, A | 1 |
Boronovskaia, LE; Korman, DB; Maslova, IA | 1 |
Chatani, K; Kametani, T; Masuda, S; Shibata, K; Takase, M | 1 |
Barreras, L; Cano, R; Davila, E; Krill, E; Lewis, M; Lilenbaum, R; Lutzky, J; Schwartz, M; Siegel, L | 1 |
1 review(s) available for deoxycytidine and Pleural Effusion, Malignant
Article | Year |
---|---|
Extraordinary response of metastatic pancreatic cancer to apatinib after failed chemotherapy: A case report and literature review.
Topics: Angiogenesis Inhibitors; Antigens, Tumor-Associated, Carbohydrate; Chemoradiotherapy; Deoxycytidine; Disease-Free Survival; Fatal Outcome; Female; Gemcitabine; Humans; Liver Neoplasms; Middle Aged; Pancreatic Neoplasms; Pleural Effusion, Malignant; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyridines; Tomography, X-Ray Computed; Treatment Failure; Vascular Endothelial Growth Factor Receptor-2 | 2017 |
3 trial(s) available for deoxycytidine and Pleural Effusion, Malignant
Article | Year |
---|---|
Treatment of malignant pleural mesothelioma with carboplatin, liposomized doxorubicin, and gemcitabine: a phase II study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asbestos; Carboplatin; Deoxycytidine; Disease Progression; Doxorubicin; Female; Gemcitabine; Humans; Liposomes; Male; Maximum Tolerated Dose; Mesothelioma; Middle Aged; Neoplasm Staging; Pleural Effusion, Malignant; Prognosis; Survival Rate; Time Factors | 2008 |
Combined intrapleural and intravenous chemotherapy, and pulmonary irradiation, for treatment of patients with lung cancer presenting with malignant pleural effusion. A pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Infusions, Intravenous; Injections, Intralesional; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Pleural Effusion, Malignant; Pleurodesis; Radiotherapy, Adjuvant; Survival Rate; Treatment Outcome | 2003 |
Gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: a phase II study.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Confidence Intervals; Deoxycytidine; Female; Gemcitabine; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Pleural Effusion, Malignant; Remission Induction; Survival Rate; Thrombocytopenia; Vinblastine; Vinorelbine | 2000 |
9 other study(ies) available for deoxycytidine and Pleural Effusion, Malignant
Article | Year |
---|---|
Massive malignant pleural effusion due to lung adenocarcinoma in 13-year-old boy.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adenocarcinoma, Mucinous; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cisplatin; Deoxycytidine; Drainage; Gemcitabine; Humans; Lung Neoplasms; Male; Pleural Effusion, Malignant; Tomography, X-Ray Computed | 2016 |
Pulmonary metastases from low grade sarcoma in a patient with pulmonary sarcoidosis. Sarcoidosis or sarcoid-like reaction?
Topics: Aged; Antimetabolites, Antineoplastic; Biopsy; Deoxycytidine; Diagnosis, Differential; Drainage; Gemcitabine; Humans; Lung Neoplasms; Male; Multiple Pulmonary Nodules; Neoplasm Grading; Pleural Effusion, Malignant; Predictive Value of Tests; Sarcoidosis, Pulmonary; Sarcoma; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
Expression of excision repair cross-complementation group 1 protein predicts poor outcome in advanced non-small cell lung cancer patients treated with platinum-based doublet chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; bcl-2-Associated X Protein; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Disease Progression; DNA-Binding Proteins; Drug Resistance, Neoplasm; Endonucleases; Female; Gemcitabine; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Platinum; Pleural Effusion, Malignant; Prognosis; Proto-Oncogene Proteins c-bcl-2; Recurrence; Survival Analysis; Treatment Outcome; Tumor Suppressor Protein p53 | 2009 |
DNA repair polymorphisms and treatment outcomes of patients with malignant mesothelioma treated with gemcitabine-platinum combination chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cell Cycle Proteins; Deoxycytidine; DNA; DNA Repair; DNA-Binding Proteins; Female; Follow-Up Studies; Gemcitabine; Humans; Male; Mesothelioma; Middle Aged; Neoplasm Staging; Nuclear Proteins; Peritoneal Neoplasms; Platinum; Pleural Effusion, Malignant; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Prognosis; Rad51 Recombinase; Survival Rate; X-ray Repair Cross Complementing Protein 1 | 2012 |
Recombinant human endostatin (endostar) decreased recurrent ascites, pleural fluid and ascitic VEGF in a case of advanced mesothelioma.
Topics: Adult; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Ascites; Ascitic Fluid; Cisplatin; Deoxycytidine; Drug Resistance, Neoplasm; Endostatins; Gemcitabine; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Neoplasm Staging; Pleural Effusion, Malignant; Recombinant Proteins; Secondary Prevention; Severity of Illness Index; Treatment Outcome; Vascular Endothelial Growth Factor A | 2012 |
[Effective treatment with the additional administration of UFT for refractory malignant pleural effusion secondary to adenocarcinoma of the lung after the treatment regimen of gemcitabine and vinorelbine].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Administration Schedule; Drug Combinations; Drug Resistance, Neoplasm; Gemcitabine; Humans; Lung Neoplasms; Male; Pleural Effusion, Malignant; Tegafur; Uracil; Vinblastine; Vinorelbine | 2003 |
A case of diffuse pleural mesothelioma in which contralateral exploratory thoracoscopy assisted the selection of therapy.
Topics: Aged; Biopsy, Needle; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Follow-Up Studies; Gemcitabine; Humans; Immunohistochemistry; Male; Mesothelioma; Neoplasm Invasiveness; Neoplasm Staging; Pleural Effusion, Malignant; Pleural Neoplasms; Risk Assessment; Thoracoscopy; Tomography, X-Ray Computed | 2005 |
[The use of gemcitabine in the treatment of patients with mesothelioma].
Topics: Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Female; Gemcitabine; Humans; Mesothelioma; Pleural Effusion, Malignant; Treatment Outcome | 2006 |
[A case of adenocarcinoma of unknown primary site successfully treated with gemcitabine monotherapy].
Topics: Adenocarcinoma; Aged; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Biomarkers, Tumor; CA-19-9 Antigen; Deoxycytidine; Female; Gemcitabine; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Neoplasms, Unknown Primary; Pancreatic Neoplasms; Pleural Effusion, Malignant; Tomography, X-Ray Computed | 2006 |